Repligen share price logo

Repligen

NASDAQ: RGEN

Large Cap

$176.27

-5.76

(-3.16%)

as on

Repligen Stock Performance

as on August 29, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $175.78
    $181.15
    downward going graph

    0.28%

    Downside

    2.77%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $100.99
    $188.73
    downward going graph

    42.71%

    Downside

    7.07%

    Upside

    downward going graph

Repligen share price movements today

Previous Close
$182.03
Open
$180.81
Volume
684.5K
Market Cap
$10.2B
Day's Low - High
$175.78 - $181.15
52 Week Low - High
$100.99 - $188.73

Repligen Historical Returns

1 Month Return
+ 25.24 %
3 Month Return
+ 48.32 %
1 Year Return
+ 49 %
3 Year Return
+ 9.58 %
5 Year Return
-34.01 %

Repligen Stock Fundamentals & Key Indicators

Check Repligen market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$10.2B

EPS (TTM)

0.74

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.66%

PE Ratio (TTM)

226.34

Industry PE ratio

24.749285714285715

PEG Ratio

0.27434889434889426

EBITDA

121.8M

Revenue (TTM)

785.1M

Profit Margin

51.05%

Return On Equity TTM

1.98%

Repligen Stock Valuation

Track how Repligen P/E has moved over time to understand its valuation trends.

Repligen in the last 5 years

  • Overview

  • Trends

Lowest (-312.91x)

December 31, 2024

Industry (24.75x)

December 31, 2025

Today (188.34x)

December 31, 2025

Highest (281.45x)

December 31, 2023

LowHigh

Today’s Price to Earnings Ratio: 188.34x

Repligen vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Repligen with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$10.2B-34.01%226.3451.05%NA
BUY$132.7B6.24%45.3466.68%NA
BUY$36.7B-11.96%55.95.92%48.97%
BUY$51.7B-24.29%54.8146.12%2.06%
StrongBuy$46.5BNA40.2925.02%NA

Stock Returns calculator for Repligen Stock including INR - Dollar returns

The Repligen stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Repligen investment value today

Current value as on today

₹1,57,093

Returns

₹57,093

(+57.09%)

Returns from Repligen Stock

₹44,283 (+44.28%)

Dollar Impact

₹12,811 (+12.81%)

Analyst Recommendation on Repligen Stock

Based on 13 analysts

BUY

92.31%

Buy

7.69%

Hold

0.00%

Sell

Based on 13 analysts, 92.3076923076923% of analysts recommend a 'BUY' rating for Repligen. Average target price of $185.7

Repligen Share Price Target

Get share price movements and forecasts by analysts on Repligen.

What analysts predicted

5.08%UPSIDE

Target Price

$185.7

Current Price

$176.27

Analyzed by

13 Analysts

Target

$185.70

Repligen target price $185.7, a slight upside of 5.08% compared to current price of $176.27. According to 13 analysts rating.

Indian Investors' Interest in Repligen Stock

Search interest for Repligen Stock has increased by 195% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:195% versus previous 30 day period

Repligen Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
153
158
154
167
169
182
188
197
194
204
Gross Profit
76
73
77
38
90
91
100
93
98
108
Operating Income
3
7
-7
-36
6
13
16
18
17
11
EBITDA
30
35
21
2
36
48
46
44
32
-2
Interest Expense
5
5
5
5
5
5
27
5
5
-17
Depreciation
21
21
17
35
23
24
24
19
24
-24
Income Before Tax
3
9
-1
-38
7
18
17
19
1
14
Income Tax Expense
0
3
0
-4
2
3
2
5
-6
9
Net Income
3
5
0
-33
5
14
14
13
8
5
Net Profit Margin
50.13%
46.17%
50.03%
23.18%
53.65%
49.98%
53.24%
47.21%
50.70%
53.08%

Repligen Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
141
194
270
366
670
801
632
634
738
Gross Profit
74
108
138
194
391
455
278
274
347
Operating Income
14
25
40
81
167
224
47
-35
59
EBITDA
24
41
56
98
203
277
145
80
164
Interest Expense
6
6
9
12
12
2
10
22
23
Depreciation
10
15
20
27
38
57
86
86
78
Income Before Tax
7
21
26
59
153
219
56
-27
62
Income Tax Expense
-21
4
4
0
25
33
21
-1
13
Net Income
28
16
21
59
128
185
35
-25
48
Net Profit Margin
52.53%
55.70%
51.15%
53.06%
58.35%
56.85%
44.03%
43.29%
47.09%

Repligen Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
3
3
0
-33
5
14
14
13
8
5
Operating Cash Flow
44
42
49
39
15
28
48
25
28
32
Investing Cash Flow
-8
-7
-5
-64
-74
-7
-7
-208
-3
-2
Financing Cash Flow
-8
-5
-69
1
-5
-10
0
0
-5
-6
Change in Cash
29
28
-25
-26
-60
11
39
-182
16
24

Repligen Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
28
16
21
59
128
185
41
-25
48
Operating Cash Flow
17
32
67
62
119
172
113
175
117
Investing Cash Flow
-98
-14
-205
-201
-221
-233
-123
-86
-298
Financing Cash Flow
129
3
484
305
0
-13
248
-82
-15
Change in Cash
51
20
343
179
-113
-80
227
6
-191

Mutual Funds that own Repligen Stock

Check out the Mutual Funds with significant holdings in Repligen.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
7.479308%
4220994
T. ROWE PRICE NEW HORIZONS FUND, INC.
2.13073%
1202491
Fidelity Select Portfolios
1.715228%
968000
Fidelity Concord Street Trust
1.614517%
911163
IVY FUNDS
1.585022%
894517

Global Institutional Holdings in Repligen

Funds
Holdings
iShares
8.91%
Vanguard
8.18%
Lee Ainslie
3.52%
SPDR
1.74%
First Trust
1.12%

Repligen News & Key Events

  • img

    Today's Timeline - 26 August

    Wed, 05:00 PM

    -

    Repligen Corporation to participate in Wells Fargo Healthcare Conference on September 9th with CEO and CFO presenting.

Insights on Repligen

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, RGEN has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, RGEN has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 194.25M → 204.12M (in $), with an average increase of 4.8% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, RGEN stock has moved up by 42.2%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 4 quarters, 14.91M → 5.00M (in $), with an average decrease of 29.4% per quarter

About Repligen

Repligen Corporation, a life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally. The company's products include hollow fiber consumables, KRM chromatography system, resins for new modalities, PATsmart MAVERICK and PATsmart MAVEN for real-time monitoring and control of critical bioprocess parameters, PATsmart REBEL, an at-line cell culture media analyzer; and PATsmart ZipChip, a high-resolution sample separations device, PATsmart SoloVPE slope spectroscopy system, and SoloVPE PLUS System. It offers Protien A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company also provides chromatography products, including OPUS pre-packed chromatography columns, which are used in the purification and quality control of biological drugs, as well as ELISA test kits. In addition, it offers filtration products, such as XCell ATF Cell Retention Systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration, buffer exchange, and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; and ProConnex TFDF flow paths. Further, it provides process analytics products, such as slope spectroscopy systems. The company offers its products under the OPUS, XCell, XCell ATF, TFDF, KrosFlo, SIUS, ProConnex, Spectra/Por, NGL-Impact, SoloVPE, FlowVPE, RPM, XO, Metenova MixOne, and AVIPure and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has a collaboration agreement with Navigo Proteins GmbH to develop multiple affinity ligands. The company was incorporated in 1981 and is headquartered in Waltham, Massachusetts.
OrganisationRepligen
HeadquartersBuilding 1, Waltham, MA, United States, 02453
IndustryMedical Instruments & Supplies
CEOMr. Olivier Loeillot
E-voting on sharesClick here to vote

Key Management of Repligen

Name

Title

Mr. Ralf Kuriyel

Senior Vice President of Research & Development

Mr. Brian Douglass

Senior VP & Chief Product Officer

Ms. Heather Ems

Chief Information Officer

Mr. Jacob K. Johnson C.F.A.

Vice President of Investor Relations

Mr. Neil Whitfield

Senior Vice President of Sales

Mr. Olivier Loeillot

President, CEO & Director

Mr. Jason K. Garland

CFO & Chief Compliance Officer

Mr. Anthony J. Hunt

Advisor

Ms. Violetta Hughes

Chief Accounting Officer

Mr. George A Scott Jr., J.D., M.B.A.

Senior VP & General Counsel

FAQs

What is Repligen share price today?

Repligen share price today is $176.27 as on at the close of the market. Repligen share today touched a day high of $181.15 and a low of $175.78.

What is the 52 week high and 52 week low for Repligen share?

Repligen share touched a 52 week high of $188.73 on and a 52 week low of $100.99 on . Repligen stock price today i.e. is closed at $176.27,which is 6.60% down from its 52 week high and 74.54% up from its 52 week low.

What is Repligen's market capitalisation today?

Repligen market capitalisation is $0.01T as on .

How to invest in Repligen Stock (RGEN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Repligen on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Repligen Shares that will get you 0.0085 shares as per Repligen share price of $176.27 per share as on August 29, 2026 at 8:46 am IST.

What is the minimum amount required to buy Repligen Stock (RGEN) from India?

Indian investors can start investing in Repligen (RGEN) shares with as little as ₹95.368 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹953.68 in Repligen stock (as per the Rupee-Dollar exchange rate as on ). Based on Repligen share’s latest price of $176.27 as on August 29, 2026 at 8:46 am IST, you will get 0.0567 shares of Repligen. Learn more about fractional shares .

What are the returns that Repligen has given to Indian investors in the last 5 years?

Repligen stock has given -34.01% share price returns and 30.18% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?